We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+9.64%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$27.3B
AUM Growth
+$1.22B
(+4.7%)
Cap. Flow
-$932M
Cap. Flow
% of AUM
-3.41%
Top 10 Holdings %
Top 10 Hldgs %
60.57%
Holding
1,588
New
70
Increased
176
Reduced
495
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$67.4M |
| 3 |
XIFR
XPLR Infrastructure LP
XIFR
|
+$63.8M |
| 4 |
UnitedHealth
UNH
|
+$57.4M |
| 5 |
Danaher
DHR
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$760M |
| 2 |
Amazon
AMZN
|
+$68.5M |
| 3 |
AbbVie
ABBV
|
+$54.2M |
| 4 |
PPLI
People Inc
PPLI
|
+$36.8M |
| 5 |
PNC Financial Services
PNC
|
+$29.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 44.09% |
| 2 | Technology | 18.28% |
| 3 | Healthcare | 10.34% |
| 4 | Consumer Discretionary | 7.89% |
| 5 | Communication Services | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
351
DELISTED
Walgreens Boots Alliance
WBA
| $1.33M | ﹤0.01% |
46,528
-4,673
| -9% | -$152K |
|
|
SFE
352
DELISTED
Safeguard Scientifics, Inc.
SFE
| $1.32M | ﹤0.01% |
800,896
-85,865
| -10% | -$150K |
|
353
Carrier Global
CARR
$57.2B
| $1.24M | ﹤0.01% |
24,990
+228
| +0.9% | +$10K |
|
|
CTRA
354
DELISTED
Coterra Energy
CTRA
| $1.23M | ﹤0.01% |
48,540
| – | – |
|
355
Mueller Industries
MLI
$14.1B
| $1.21M | ﹤0.01% |
55,600
+49,600
| +827% | +$943K |
|
356
Norfolk Southern
NSC
$78.8B
| $1.21M | ﹤0.01% |
5,334
-1,262
| -19% | -$268K |
|
|
SEE
357
DELISTED
Sealed Air
SEE
| $1.2M | ﹤0.01% |
29,997
-1,900
| -6% | -$80.8K |
|
358
iShares Russell 1000 Value ETF
IWD
$82B
| $1.19M | ﹤0.01% |
7,536
+1
| +0% | +$153 |
|
|
OLP
359
One Liberty Properties
OLP
$548M
| $1.15M | ﹤0.01% |
56,726
-5,986
| -10% | -$126K |
|
360
Bridger Aerospace
BAER
$107M
| $1.12M | ﹤0.01% |
200,000
| – | – |
|
361
ServiceNow
NOW
$102B
| $1.09M | ﹤0.01% |
9,660
+65
| +0.7% | +$6.5K |
|
|
PARA
362
DELISTED
Paramount Global Class B
PARA
| $1.08M | ﹤0.01% |
67,699
-356
| -0.5% | -$6.43K |
|
363
iShares Gold Trust
IAU
$63B
| $1.08M | ﹤0.01% |
29,582
-41,450
| -58% | -$1.55M |
|
364
Ecolab
ECL
$75.6B
| $1.05M | ﹤0.01% |
5,608
-759
| -12% | -$131K |
|
365
Repligen
RGEN
$7.44B
| $1.01M | ﹤0.01% |
7,158
| – | – |
|
366
Unilever
UL
$131B
| $1.01M | ﹤0.01% |
17,168
-3,148
| -15% | -$187K |
|
367
Compass Minerals
CMP
$1.24B
| $1M | ﹤0.01% |
29,500
| – | – |
|
368
Duke Energy
DUK
$102B
| $997K | ﹤0.01% |
11,115
-168
| -1% | -$15.9K |
|
369
Park National Corp
PRK
$3.41B
| $995K | ﹤0.01% |
9,727
-100
| -1% | -$10.6K |
|
370
Vanguard Growth ETF
VUG
$216B
| $991K | ﹤0.01% |
21,024
-14,640
| -41% | -$635K |
|
371
Carter Bankshares
CARE
$756M
| $991K | ﹤0.01% |
67,032
| – | – |
|
|
TAST
372
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $978K | ﹤0.01% |
194,000
-23,400
| -11% | -$106K |
|
373
State Street Energy Select Sector SPDR ETF
XLE
$39.5B
| $953K | ﹤0.01% |
23,476
-1,082
| -4% | -$44.1K |
|
|
PPBI
374
DELISTED
Pacific Premier Bancorp
PPBI
| $951K | ﹤0.01% |
45,969
| – | – |
|
|
HES
375
DELISTED
Hess
HES
| $949K | ﹤0.01% |
6,980
| – | – |
|
Similar funds
SAM
First Manhattan's Q2 2023 Portfolio in Review
As of Q2 2023, First Manhattan held 1,588 positions worth $27.3B, up 4.7% from $26.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.
First Manhattan withdrew a net $932M in Q2 2023, closing 161 positions and reducing 495 holdings. Its most notable exit was Enanta Pharmaceuticals, an estimated $10.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 45% a quarter earlier, followed by Technology and Healthcare.
Against the trend, First Manhattan opened a new position in Mersana Therapeutics worth $1.87M.
- First Manhattan's largest Q2 2023 buy was Mersana Therapeutics: 22,784 shares worth $1.87M.
- First Manhattan added most to Thermo Fisher Scientific in Q2 2023, an estimated $128M increase.
- First Manhattan's biggest Q2 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $760M.
- First Manhattan fully exited Enanta Pharmaceuticals in Q2 2023, selling an estimated $10.7M.
- First Manhattan's ten largest holdings make up 61% of its $27.3B portfolio in Q2 2023.
- First Manhattan opened 70 new positions and closed 161 in Q2 2023.
- First Manhattan's portfolio value rose 4.7% quarter-over-quarter to $27.3B.
Based on First Manhattan's 13F filing for Q2 2023, filed 14 Aug 2023.